{"id":"https://openalex.org/W2053765781","doi":"https://doi.org/10.1056/nejm198806023182204","title":"Association of Antibody to Histone Complex H2A\u2013H2B with Symptomatic Procainamide-Induced Lupus","display_name":"Association of Antibody to Histone Complex H2A\u2013H2B with Symptomatic Procainamide-Induced Lupus","publication_year":1988,"publication_date":"1988-06-02","ids":{"openalex":"https://openalex.org/W2053765781","doi":"https://doi.org/10.1056/nejm198806023182204","mag":"2053765781","pmid":"https://pubmed.ncbi.nlm.nih.gov/3259287"},"language":"en","primary_location":{"id":"doi:10.1056/nejm198806023182204","doi":"https://doi.org/10.1056/nejm198806023182204","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejm198806023182204","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077153810","display_name":"Mark C. Totoritis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark C. Totoritis","raw_affiliation_strings":["W.M. Keck Autoimmune Disease Center, Research Institute of Scripps Clinic, La Jolla, Calif. 92037"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"W.M. Keck Autoimmune Disease Center, Research Institute of Scripps Clinic, La Jolla, Calif. 92037","institution_ids":["https://openalex.org/I4210146328"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065446697","display_name":"Eng M. Tan","orcid":"https://orcid.org/0000-0002-8711-3248","observed_orcids":["https://orcid.org/0000-0002-8711-3248"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eng M. Tan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086760549","display_name":"Edward M. McNally","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward M. McNally","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111488529","display_name":"R L Rubin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Rubin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.3178,"has_fulltext":false,"cited_by_count":114,"citation_normalized_percentile":{"value":0.9777732,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"318","issue":"22","first_page":"1431","last_page":"1436"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-lupus-erythematosus","display_name":"drug-induced lupus","score":0.921999990940094},{"id":"https://openalex.org/keywords/anti-histone-antibodies","display_name":"anti-histone antibodies","score":0.8059999942779541},{"id":"https://openalex.org/keywords/igg","display_name":"IgG","score":0.8429999947547913},{"id":"https://openalex.org/keywords/antinuclear-antibodies","display_name":"antinuclear antibodies","score":0.9800000190734863},{"id":"https://openalex.org/keywords/diagnostic-biomarkers","display_name":"diagnostic biomarkers","score":0.6489999890327454},{"id":"https://openalex.org/keywords/lupus-pathogenesis","display_name":"lupus pathogenesis","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C2777028498","wikidata":"https://www.wikidata.org/wiki/Q417597","display_name":"Procainamide","level":2,"score":0.9666898846626282},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8454406261444092},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.7988765835762024},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.7952225208282471},{"id":"https://openalex.org/C149443304","wikidata":"https://www.wikidata.org/wiki/Q185390","display_name":"Anti-nuclear antibody","level":4,"score":0.6763619184494019},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4715200662612915},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.45551860332489014},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.44048619270324707},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.426737517118454},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4175947904586792},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.41405919194221497},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.32416749000549316},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.2747432589530945},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13040542602539062}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000974","descriptor_name":"Antibodies, Antinuclear","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D002308","descriptor_name":"Cardiolipins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006151","descriptor_name":"Guanosine","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006657","descriptor_name":"Histones","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011342","descriptor_name":"Procainamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejm198806023182204","doi":"https://doi.org/10.1056/nejm198806023182204","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejm198806023182204","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:3259287","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3259287","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1655645242","display_name":"GENERAL CLINICAL RESEARCH CENTER","funder_award_id":"M01RR000833","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G6837800451","display_name":"MECHANISMS UNDERLYING PROCAINAMIDE-INDUCED AUTOIMMUNITY","funder_award_id":"R01AR034358","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W97674068","https://openalex.org/W152532295","https://openalex.org/W1486947064","https://openalex.org/W1506949126","https://openalex.org/W1546252777","https://openalex.org/W1968921469","https://openalex.org/W1985710645","https://openalex.org/W1992115723","https://openalex.org/W1992266184","https://openalex.org/W2028815663","https://openalex.org/W2029625233","https://openalex.org/W2038468561","https://openalex.org/W2042393423","https://openalex.org/W2060944400","https://openalex.org/W2065161375","https://openalex.org/W2073459406","https://openalex.org/W2079180127","https://openalex.org/W2084768869","https://openalex.org/W2089303733","https://openalex.org/W2110818039","https://openalex.org/W2143947466","https://openalex.org/W2146205908","https://openalex.org/W2150727488","https://openalex.org/W2160209304","https://openalex.org/W2162755974","https://openalex.org/W2178797281","https://openalex.org/W2409413993","https://openalex.org/W2417549700","https://openalex.org/W2418656523","https://openalex.org/W4236698846"],"related_works":["https://openalex.org/W2065161375","https://openalex.org/W1510356002","https://openalex.org/W2060944400","https://openalex.org/W2116017651","https://openalex.org/W7098304153","https://openalex.org/W1992266184","https://openalex.org/W2314911228","https://openalex.org/W2039390741","https://openalex.org/W2338996165","https://openalex.org/W1977892155"],"abstract_inverted_index":{"Antinuclear":[0],"antibodies":[1,41,61,77,122,190,206],"develop":[2],"in":[3,20,51,78,111,125,140,147,165],"most":[4],"patients":[5,84,92,118,131,141,148],"who":[6],"are":[7,193],"given":[8],"prolonged":[9],"procainamide":[10,106,145],"therapy,":[11],"but":[12],"clinical":[13],"symptoms":[14,101],"resembling":[15],"those":[16],"of":[17,26,69,89,96,100,105,167,172],"lupus":[18,35,150],"appear":[19],"only":[21,128],"15":[22],"to":[23,42,123,127,191,207],"20":[24,79,116,168],"percent":[25],"such":[27],"persons.":[28],"No":[29],"objective":[30],"marker":[31,65,198],"for":[32,66,75,109,199],"symptomatic":[33,80,91,113,117,169,182,210],"procainamide-induced":[34,70,200],"has":[36,56],"been":[37,49,57],"described.":[38],"However,":[39],"IgG":[40,121,156,189],"the":[43,90,103,112,220],"histone":[44],"complex":[45],"H2A-H2B":[46,192,208],"have":[47],"previously":[48],"reported":[50],"this":[52,217],"disorder,":[53],"and":[54,81,146,170,183,196,209,219],"it":[55],"suggested":[58],"that":[59,177,188],"antiguanosine":[60,157],"may":[62],"be":[63],"a":[64,194,213],"major":[67],"manifestations":[68,95],"lupus.":[71,201],"We":[72,186],"therefore":[73],"tested":[74],"these":[76],"31":[82,173],"asymptomatic":[83,130,174,184],"treated":[85,143],"with":[86,144,149,162],"procainamide.":[87],"Most":[88],"had":[93,119],"multiple":[94],"drug-induced":[97],"lupus;":[98],"resolution":[99],"after":[102],"discontinuation":[104],"was":[107,138,158],"required":[108],"inclusion":[110],"group.":[114],"All":[115],"elevated":[120,159],"H2A-H2B,":[124],"contrast":[126],"2":[129],"(P":[132],"less":[133],"than":[134],"0.001).":[135],"This":[136],"activity":[137],"absent":[139],"not":[142,179],"induced":[151],"by":[152],"hydralazine":[153],"or":[154],"quinidine.":[155],"as":[160],"compared":[161],"normal":[163],"controls":[164],"13":[166],"19":[171],"patients--a":[175],"finding":[176],"did":[178],"distinguish":[180],"between":[181,205,216],"patients.":[185],"conclude":[187],"sensitive":[195],"specific":[197],"The":[202],"striking":[203],"correlation":[204],"disease":[211],"suggests":[212],"possible":[214],"association":[215],"antibody":[218],"underlying":[221],"pathogenic":[222],"events.":[223]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}